DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,935,789 | +12.0% | 100,507 | +8.4% | 0.38% | +17.1% |
| Q2 2023 | $22,255,920 | -0.7% | 92,733 | +4.2% | 0.33% | -5.2% |
| Q1 2023 | $22,423,496 | -1.3% | 88,968 | +3.9% | 0.34% | -5.7% |
| Q4 2022 | $22,723,932 | +0.2% | 85,615 | -2.5% | 0.37% | -8.5% |
| Q3 2022 | $22,678,000 | +8.0% | 87,795 | +6.0% | 0.40% | +13.6% |
| Q2 2022 | $21,006,000 | -12.3% | 82,850 | +1.4% | 0.35% | +3.5% |
| Q1 2022 | $23,964,000 | -10.9% | 81,697 | -0.1% | 0.34% | -4.8% |
| Q4 2021 | $26,898,000 | +11.1% | 81,760 | +2.8% | 0.36% | +3.8% |
| Q3 2021 | $24,209,000 | +13.8% | 79,519 | +0.3% | 0.34% | +13.5% |
| Q2 2021 | $21,269,000 | +18.1% | 79,254 | -0.9% | 0.30% | +8.6% |
| Q1 2021 | $18,003,000 | +7.1% | 79,987 | +5.7% | 0.28% | -0.7% |
| Q4 2020 | $16,807,000 | +1.2% | 75,660 | -1.9% | 0.28% | -13.0% |
| Q3 2020 | $16,611,000 | +12.0% | 77,140 | -8.0% | 0.32% | +5.6% |
| Q2 2020 | $14,827,000 | +34.3% | 83,852 | +5.1% | 0.31% | +12.9% |
| Q1 2020 | $11,039,000 | +0.2% | 79,754 | +11.1% | 0.27% | +16.3% |
| Q4 2019 | $11,017,000 | +18.3% | 71,783 | +11.3% | 0.23% | +12.6% |
| Q3 2019 | $9,312,000 | +0.6% | 64,473 | -0.5% | 0.21% | +1.0% |
| Q2 2019 | $9,259,000 | +32.6% | 64,790 | +22.5% | 0.20% | +30.6% |
| Q1 2019 | $6,981,000 | +47.3% | 52,869 | +15.1% | 0.16% | +34.2% |
| Q4 2018 | $4,738,000 | -16.0% | 45,949 | -11.5% | 0.12% | -6.4% |
| Q3 2018 | $5,643,000 | +11.5% | 51,945 | +1.2% | 0.12% | +0.8% |
| Q2 2018 | $5,063,000 | -5.6% | 51,314 | -6.3% | 0.12% | -8.1% |
| Q1 2018 | $5,364,000 | +19.7% | 54,778 | +4.8% | 0.14% | +13.4% |
| Q4 2017 | $4,483,000 | 0.0% | 52,261 | 0.0% | 0.12% | +2.6% |
| Q3 2017 | $4,483,000 | -37.3% | 52,261 | -38.4% | 0.12% | -41.4% |
| Q2 2017 | $7,154,000 | -11.5% | 84,791 | -10.3% | 0.20% | -13.9% |
| Q1 2017 | $8,083,000 | – | 94,491 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |